This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/β-catenin signaling pathway
Xin Li, Lei Xue, Qin Peng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsWnt/β-catenin signaling in development and cancer · Microtubule and mitosis dynamics · Circular RNAs in diseases
Oncol Lett 15: 8470–8476, 2018; DOI: 10.3892/ol.2018.8416
Following the publication of the above paper, a concerned reader drew to the Editor's attention that the β-actin control blots shown for Figs. 4B and 5B held several protein bands in common, where different experimental conditions were described; moreover, the Lamin B data in Fig. 5A had apparently already appeared in a figure in a paper published in the journal Oncotarget that was written by different authors at different research institutes. Upon performing an independent analysis of the data in the Editorial Office, it came to light that the migration and invasion assay data shown in Fig. 2A-D and the immunofluorescence assay data in Fig. 4E and F were also strikingly similar to data that had already appeared in previously published papers in different journals written by different authors at different research institutes.
Given that the abovementioned data had already been published previously in a range of different journals, the Editor of Oncology Letters has decided that this article should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.